Champions Oncology, Inc. Share Price
NASDAQ: CSBR | Micro CapChampions Oncology, Inc. Stock Performance
Champions Oncology, Inc. Share Price Today
As of 30 October 2026, Champions Oncology, Inc.'s share price is $4.84. The stock opened at $4.84, compared to its previous close of $4.82. During today's trading session, Champions Oncology, Inc.'s share price traded between $4.84 and $4.84, with an average price of $4.84. Over the past 52 weeks, the stock has recorded a high of $7.54 and a low of $4.64. In terms of performance, Champions Oncology, Inc.'s share price has declined by 18.52% over the last six months and is down 28.51% on a year-on-year basis.
Champions Oncology, Inc. Share Price Chart
Champions Oncology, Inc. Quarterly Profit & Loss
All figures in USD
Champions Oncology, Inc. Annual Profit & Loss
All figures in USD
About Champions Oncology, Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Champions Oncology, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.90 | $4.84 | +0.62% |
Sep 2026 | $5.07 | $4.81 | -3.80% |
Aug 2026 | $5.11 | $5.00 | -12.59% |
Jul 2026 | $5.99 | $5.72 | -11.46% |
Jun 2026 | $5.71 | $6.46 | +11.38% |
May 2026 | $5.92 | $5.80 | -2.36% |
Apr 2026 | $5.90 | $5.94 | +3.13% |
Mar 2026 | $6.13 | $5.76 | -3.27% |
Feb 2026 | $6.83 | $5.96 | -18.48% |
Jan 2026 | $6.64 | $7.30 | -0.48% |
Dec 2025 | $6.11 | $7.34 | +12.58% |
Nov 2025 | $6.75 | $6.52 | -3.69% |